MANGALAM vs SIGACHI: Stock Comparison

Mangalam Drugs And Organics Limited vs Sigachi Industries Limited

Live data: 22 July 2026, 2:57 PM IST • Source: NSE and company filings

Sigachi Industries Limited is the larger company by market capitalisation. Sigachi Industries Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Mangalam Drugs And Organics Limited and Sigachi Industries Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, MANGALAM is more favourable on 2 of 11 scored metrics and SIGACHI on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SIGACHI is the larger company
₹1,011 Cr vs ₹43 Cr
EPS
SIGACHI has higher earnings per share
₹-1.46 vs ₹-28.05
Dividend Yield
SIGACHI has a higher dividend yield
0.45% vs 0%
Revenue Growth (TTM YoY)
SIGACHI has faster revenue growth
16.22% vs -7.5%
Qtr Sales Growth
MANGALAM has stronger quarterly sales growth
-7.54% vs -11.6%
Qtr Profit Growth
SIGACHI has stronger quarterly profit growth
-70.9% vs -22,467%
ROE
SIGACHI has a higher ROE
-15.66% vs -35.2%
ROCE
SIGACHI has a higher ROCE
15.5% vs -14.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMANGALAMSIGACHI
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMANGALAMSIGACHI
Live Price₹27.08₹21.03
Day Change-0.66%-4.23%
Volume25,35632.76 L
52-Week High₹95₹46.73
52-Week Low₹22.8₹16.65
Distance from 52W High-71.49%-55%

Valuation

MetricMANGALAMSIGACHI
Market Cap₹43 Cr₹1,011 Cr
P/E Ratio-12.13x
P/B Ratio1.9x
EPS₹-28.05₹-1.46
Book Value₹65.12₹15.72
Dividend Yield0%0.45%

Growth

MetricMANGALAMSIGACHI
Revenue Growth (TTM YoY)-7.5%16.22%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-7.54%-11.6%
Qtr Profit Growth-22,467%-70.9%

Profitability & Leverage

MetricMANGALAMSIGACHI
ROE-35.2%-15.66%
ROCE-14.3%15.5%
Net Margin-19.13%-17.33%
Operating Margin-6.42%-15.44%
Debt to Equity1.02x0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricMANGALAMSIGACHI
Promoter Holding35.65%36.69% 3.01 pp
FII Holding0.11% 0.21 pp1.3% 2.03 pp
DII Holding0%0%
Public Holding64.24% 0.22 pp62.01% 5.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Mangalam Drugs And Organics Limited and Sigachi Industries Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.